# Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

> **NCT01004523** · — · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 135 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **GENETIC:** fluorescence in situ hybridization
- **GENETIC:** loss of heterozygosity analysis
- **GENETIC:** polymerase chain reaction
- **OTHER:** flow cytometry
- **OTHER:** immunohistochemistry staining method

## Key facts

- **NCT ID:** NCT01004523
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1995-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2016-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004523, "Study of Tissue and Blood Samples From Patients With Low-Grade Glioma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01004523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*